Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Lyon Centre at MRC Harwell (MLC) is located in an expanding science and innovation campus in Oxfordshire and is an internationally renowned centre at the forefront of genetics research. As the hub
-
The Mary Lyon Centre at MRC Harwell (MLC) is located in an expanding science and innovation campus in Oxfordshire and is an internationally renowned centre at the forefront of genetics research. As the hub
-
Mary Lyon Centre at MRC Harwell (MLC) National facility for mouse genetics | Mary Lyon Centre (mrc.ac.uk) is located in an expanding science and innovation campus in Oxfordshire and is an
-
application to medicine. Funded by the MRC as part of UK Research and Innovation , the LMS has a collaborative working culture and new state-of-the-art building based in the heart of West London in
-
and international community for the exchange of ideas and technical innovation. UK Research and Innovation is a new entity that brings together nine partners to create an independent organisation with a
-
and international community for the exchange of ideas and technical innovation. UK Research and Innovation is a new entity that brings together nine partners to create an independent organisation with a
-
technical innovation. UK Research and Innovation is a new entity that brings together nine partners to create an independent organisation with a strong voice for research and innovation, more information can
-
the understanding of biology and its application to medicine. Funded by the MRC as part of UK Research and Innovation , the LMS has a collaborative working culture and new state-of-the-art building based in
-
the understanding of biology and its application to medicine. Funded by the MRC as part of UK Research and Innovation , the LMS has a collaborative working culture and new state-of-the-art building based in
-
Institute / Unit Information 1 The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), has invested a total of £30M over 5 years to establish the Nucleic Acid Therapy Accelerator